Plasma homocysteine levels and folate status in children with sickle cell anemia

Hector M. Rodriguez-Cortes, James C. Griener, Keith Hyland, Teodoro Bottiglieri, Michael J. Bennett, Barton A. Kamen, George R. Buchanan

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

Purpose: A sensitive inverse relationship between plasma homocysteine concentration and folate status has been demonstrated. Although children with sickle cell anemia (SCA) are at potential risk for folate deficiency, plasma homocysteine levels have not been reported in such patients. Therefore, a study was designed to assess plasma homocysteine levels as a marker of folate status. Design: Plasma homocysteine concentrations were measured in 120 children with SCA (102 in steady state and 18 during an acute complication) who had never received supplemental folic acid. Folate status was directly assessed in 34 of these patients. Results: Plasma homocysteine levels in the patients with SCA and control subjects were similar. The mean value ± 1 SD was 5.8 ± 2.5 μmol/L (range, 1.6 to 14.1 μmol/L) in the patients with SCA and 6.1 ± 2.7 μmol/L (range, 1.7 to 15.3 μmol/L) in 73 pediatric control subjects. In a subpopulation of the study group (34 children), simultaneous serum folate, red cell folate, and total homocysteine concentrations were also measured. Their serum folate and red cell folate concentrations were normal: 12.4 ± 10.0 nmol/L (range, 1 to 42 nmol/L) and 604 ± 374.7 nmol/L (range, 205 to 1741 nmol/L), respectively. There was no correlation of plasma homocysteine concentration with various clinical or laboratory measures or with red cell folate concentration. Conclusion: Folate stores in children with SCA not receiving folic acid supplements are adequate despite an underlying hemolytic anemia.

Original languageEnglish (US)
Pages (from-to)219-223
Number of pages5
JournalJournal of Pediatric Hematology/Oncology
Volume21
Issue number3
DOIs
StatePublished - May 1999

Fingerprint

Sickle Cell Anemia
Homocysteine
Folic Acid
Hemolytic Anemia
Serum
Pediatrics

Keywords

  • Folic acid
  • Homocysteine
  • Sickle cell

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Oncology
  • Hematology

Cite this

Rodriguez-Cortes, H. M., Griener, J. C., Hyland, K., Bottiglieri, T., Bennett, M. J., Kamen, B. A., & Buchanan, G. R. (1999). Plasma homocysteine levels and folate status in children with sickle cell anemia. Journal of Pediatric Hematology/Oncology, 21(3), 219-223. https://doi.org/10.1097/00043426-199905000-00010

Plasma homocysteine levels and folate status in children with sickle cell anemia. / Rodriguez-Cortes, Hector M.; Griener, James C.; Hyland, Keith; Bottiglieri, Teodoro; Bennett, Michael J.; Kamen, Barton A.; Buchanan, George R.

In: Journal of Pediatric Hematology/Oncology, Vol. 21, No. 3, 05.1999, p. 219-223.

Research output: Contribution to journalArticle

Rodriguez-Cortes, HM, Griener, JC, Hyland, K, Bottiglieri, T, Bennett, MJ, Kamen, BA & Buchanan, GR 1999, 'Plasma homocysteine levels and folate status in children with sickle cell anemia', Journal of Pediatric Hematology/Oncology, vol. 21, no. 3, pp. 219-223. https://doi.org/10.1097/00043426-199905000-00010
Rodriguez-Cortes HM, Griener JC, Hyland K, Bottiglieri T, Bennett MJ, Kamen BA et al. Plasma homocysteine levels and folate status in children with sickle cell anemia. Journal of Pediatric Hematology/Oncology. 1999 May;21(3):219-223. https://doi.org/10.1097/00043426-199905000-00010
Rodriguez-Cortes, Hector M. ; Griener, James C. ; Hyland, Keith ; Bottiglieri, Teodoro ; Bennett, Michael J. ; Kamen, Barton A. ; Buchanan, George R. / Plasma homocysteine levels and folate status in children with sickle cell anemia. In: Journal of Pediatric Hematology/Oncology. 1999 ; Vol. 21, No. 3. pp. 219-223.
@article{0822a02ae7ea4b59a63bf91cedcb6aa4,
title = "Plasma homocysteine levels and folate status in children with sickle cell anemia",
abstract = "Purpose: A sensitive inverse relationship between plasma homocysteine concentration and folate status has been demonstrated. Although children with sickle cell anemia (SCA) are at potential risk for folate deficiency, plasma homocysteine levels have not been reported in such patients. Therefore, a study was designed to assess plasma homocysteine levels as a marker of folate status. Design: Plasma homocysteine concentrations were measured in 120 children with SCA (102 in steady state and 18 during an acute complication) who had never received supplemental folic acid. Folate status was directly assessed in 34 of these patients. Results: Plasma homocysteine levels in the patients with SCA and control subjects were similar. The mean value ± 1 SD was 5.8 ± 2.5 μmol/L (range, 1.6 to 14.1 μmol/L) in the patients with SCA and 6.1 ± 2.7 μmol/L (range, 1.7 to 15.3 μmol/L) in 73 pediatric control subjects. In a subpopulation of the study group (34 children), simultaneous serum folate, red cell folate, and total homocysteine concentrations were also measured. Their serum folate and red cell folate concentrations were normal: 12.4 ± 10.0 nmol/L (range, 1 to 42 nmol/L) and 604 ± 374.7 nmol/L (range, 205 to 1741 nmol/L), respectively. There was no correlation of plasma homocysteine concentration with various clinical or laboratory measures or with red cell folate concentration. Conclusion: Folate stores in children with SCA not receiving folic acid supplements are adequate despite an underlying hemolytic anemia.",
keywords = "Folic acid, Homocysteine, Sickle cell",
author = "Rodriguez-Cortes, {Hector M.} and Griener, {James C.} and Keith Hyland and Teodoro Bottiglieri and Bennett, {Michael J.} and Kamen, {Barton A.} and Buchanan, {George R.}",
year = "1999",
month = "5",
doi = "10.1097/00043426-199905000-00010",
language = "English (US)",
volume = "21",
pages = "219--223",
journal = "Journal of Pediatric Hematology/Oncology",
issn = "1077-4114",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Plasma homocysteine levels and folate status in children with sickle cell anemia

AU - Rodriguez-Cortes, Hector M.

AU - Griener, James C.

AU - Hyland, Keith

AU - Bottiglieri, Teodoro

AU - Bennett, Michael J.

AU - Kamen, Barton A.

AU - Buchanan, George R.

PY - 1999/5

Y1 - 1999/5

N2 - Purpose: A sensitive inverse relationship between plasma homocysteine concentration and folate status has been demonstrated. Although children with sickle cell anemia (SCA) are at potential risk for folate deficiency, plasma homocysteine levels have not been reported in such patients. Therefore, a study was designed to assess plasma homocysteine levels as a marker of folate status. Design: Plasma homocysteine concentrations were measured in 120 children with SCA (102 in steady state and 18 during an acute complication) who had never received supplemental folic acid. Folate status was directly assessed in 34 of these patients. Results: Plasma homocysteine levels in the patients with SCA and control subjects were similar. The mean value ± 1 SD was 5.8 ± 2.5 μmol/L (range, 1.6 to 14.1 μmol/L) in the patients with SCA and 6.1 ± 2.7 μmol/L (range, 1.7 to 15.3 μmol/L) in 73 pediatric control subjects. In a subpopulation of the study group (34 children), simultaneous serum folate, red cell folate, and total homocysteine concentrations were also measured. Their serum folate and red cell folate concentrations were normal: 12.4 ± 10.0 nmol/L (range, 1 to 42 nmol/L) and 604 ± 374.7 nmol/L (range, 205 to 1741 nmol/L), respectively. There was no correlation of plasma homocysteine concentration with various clinical or laboratory measures or with red cell folate concentration. Conclusion: Folate stores in children with SCA not receiving folic acid supplements are adequate despite an underlying hemolytic anemia.

AB - Purpose: A sensitive inverse relationship between plasma homocysteine concentration and folate status has been demonstrated. Although children with sickle cell anemia (SCA) are at potential risk for folate deficiency, plasma homocysteine levels have not been reported in such patients. Therefore, a study was designed to assess plasma homocysteine levels as a marker of folate status. Design: Plasma homocysteine concentrations were measured in 120 children with SCA (102 in steady state and 18 during an acute complication) who had never received supplemental folic acid. Folate status was directly assessed in 34 of these patients. Results: Plasma homocysteine levels in the patients with SCA and control subjects were similar. The mean value ± 1 SD was 5.8 ± 2.5 μmol/L (range, 1.6 to 14.1 μmol/L) in the patients with SCA and 6.1 ± 2.7 μmol/L (range, 1.7 to 15.3 μmol/L) in 73 pediatric control subjects. In a subpopulation of the study group (34 children), simultaneous serum folate, red cell folate, and total homocysteine concentrations were also measured. Their serum folate and red cell folate concentrations were normal: 12.4 ± 10.0 nmol/L (range, 1 to 42 nmol/L) and 604 ± 374.7 nmol/L (range, 205 to 1741 nmol/L), respectively. There was no correlation of plasma homocysteine concentration with various clinical or laboratory measures or with red cell folate concentration. Conclusion: Folate stores in children with SCA not receiving folic acid supplements are adequate despite an underlying hemolytic anemia.

KW - Folic acid

KW - Homocysteine

KW - Sickle cell

UR - http://www.scopus.com/inward/record.url?scp=0033503959&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033503959&partnerID=8YFLogxK

U2 - 10.1097/00043426-199905000-00010

DO - 10.1097/00043426-199905000-00010

M3 - Article

VL - 21

SP - 219

EP - 223

JO - Journal of Pediatric Hematology/Oncology

JF - Journal of Pediatric Hematology/Oncology

SN - 1077-4114

IS - 3

ER -